Improving antibiotic prescribing for community-acquired pneumonia in a provincial hospital in Northern Vietnam.

Objectives: To test the effectiveness of a quality improvement programme to promote adherence to national quality standards (QS) for patients hospitalized with community-acquired pneumonia (CAP), exploring the factors that hindered improvements in clinical practice.

Methods: An improvement bundle aligned to the QS was deployed using plan-do-study-act methodology in a 600 bed hospital in northern Vietnam from July 2018 to April 2019. Proposed care improvements included CURB65 score guided hospitalization, timely diagnosis and inpatient antibiotic treatment review to limit the spectrum and duration of IV antibiotic use.

WITHDRAWN: Performance of survivin mRNA as a biomarker for breast cancer among Vietnamese women.

Ahead of Print article withdrawn by publisher.

Performance of mRNA as a biomarker for breast cancer among Vietnamese women.

Objective: This study aimed to perform the reverse-transcription polymerase chain reaction (RT-PCR) to express the mRNA among patients with breast cancer in Vietnam and identify some potential associated clinical and pathological factors.

Methods: Peripheral blood (PB) samples and tissues on 43 patients with breast cancer and 21 patients with fibroids were obtained. The Real-time RT-PCR and gene sequencing techniques were employed to detect survivin gene in breast cancer cell lines and cancer tissues.

Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women.

Background: Detecting circulating tumor cells (CTCs) is a promising approach for evaluating the progression of occult metastases as well as the efficacy of treatment therapies among patients with breast cancer. A real-time reverse transcriptase polymerase chain reaction (RT-PCR) technique has been proposed for detecting CTCs due to its high sensitivity. In this study, we aimed to validate the RT-PCR technique for human mammaglobin (hMAM) mRNA detection among Vietnamese women with breast cancer.